Stock Market & Financial News
AtaiBeckley stock is soaring, and it has Eli Lilly to thank
AtaiBeckley (ATAI) shares are ripping higher on Thursday morning after pharmaceutical giant Eli Lilly (LLY) said it will acquire the clinical-stage biotechnology firm for up to $3.8 billion. Lilly has agreed to pay $6.75 a share in cash upfront ($2.8 billion) – with an additional $2.5 a share in contingent value rights (CVRs) tied to critical clinical and regulatory milestones.
LLY Can the AI Data Center Boom Become a Major Growth Driver for T1 Energy?
TE expands US solar manufacturing to capitalize on rising AI-driven electricity demand as hyperscale data centers boost utility-scale solar needs.
TE Northrop Grumman to Post Q2 Earnings: Here's What to Expect
NOC heads into Q2 earnings backed by a strong defense backlog, but investors will watch Sentinel program updates for margin impact.
NOC Can Higher Occupancy Offset Lower Admissions in CYH's Q2 Earnings?
Community Health heads into Q2 earnings with mixed operating trends as stronger occupancy meets lower admissions and a smaller hospital portfolio.
CYH 
UAL Q2 Earnings Beat as Strong Yields Offset Fuel Pressure
United Airlines' Q2 earnings beat estimates as strong yields and broad revenue gains offset soaring fuel costs and margin pressure.
UAL 
NVO Stock Up on EC Approval of Wegovy Pill to Treat Obesity
Novo Nordisk wins EC approval for a once-daily oral Wegovy pill for obesity, expanding its EU franchise with the first GLP-1 tablet for weight management.
NVO 
Why Apple's 'Standard Oil' Strategy Is Driving the Stock to All-Time Highs
Shares are headed to another record high on Thrusday. Maybe the iPhone maker should thank John D.
AAPL 
BNY Mellon Vs. State Street: Buy BNY Mellon for Elite Profit Margins and Avoid State Street's Heavy ETF Pricing Pressure
BNY Mellon (NYSE:BK | BK Price Prediction) and State Street (NYSE:STT) both posted record Q1 2026 results as the two custody giants ride a wave of client activity and foreign exchange volumes.
BNY 
Sui Price Forecast: Depressed On-Chain Data Favors 33% Drop for SUI
Sui (SUI) faces significant downward pressure as depressed on-chain metrics, including a 70% decline in stablecoin supply and plummeting network fees, signal reduced adoption. This altcoin could drop by 33% if the downtrend continues.
Eli Lilly Buys Psychedelics Maker Atai Beckley for $2.8 Billion to Develop DMT-Like Depression Drug
CNBC pharma reporter Angelica Peebles broke down the biggest psychedelics deal in Big Pharma history on July 16, 2026.
ATAI 
‘We have a plan to go overweight gold again' – Fidelity's Samson predicts return to bull market in 2027
The key trends that drove gold to an all-time high of $5,600 per ounce earlier this year remain in place, and the yellow metal will resume its bull market run in 2027, justifying a move from neutral back to overweight gold in investor portfolios, according to Ian Samson, multi-asset portfolio manager at Fidelity International.“We have a plan to go overweight gold again,” Samson said in a recent interview.
AAAU 
Can QUBT's Commercial Growth Focus Maintain Momentum in Q2
Quantum Computing has entered Q2 with a $16 million backlog, manufacturing expansion and Dirac testing underway as it pushes to scale commercial quantum hardware.
QUBT 
JBHT Q2 Earnings Beat on Intermodal Growth and Cost Discipline
J.B. Hunt's Q2 earnings beat estimates as intermodal growth, pricing and cost discipline lift revenues, operating income and margins.
JBHT 
Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now
ALHC's AI and automation are boosting margins and efficiency, but CMS risk model changes and revenue timing cloud near-term earnings visibility.
ALHC 
Eos Energy Enterprises (EOSE) Stock Drops 8.4% After Landing Major Defense Energy Storage Contract
Shares of Eos Energy Enterprises, Inc. (EOSE) dropped 8.40% to close at $4.0023 even as the company announced a significant partnership with U.S. defense authorities. The collaboration involves providing long-duration energy storage solutions for vital national security infrastructure.
Bonesupport Holding AB (publ) (BOEUF) Q2 2026 Earnings Call Transcript
Bonesupport Holding AB (publ) (BOEUF) Q2 2026 Earnings Call Transcript
BOEUF 
Here is Why Growth Investors Should Buy Yum China (YUMC) Now
Yum China (YUMC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
YUMC 
Brinker International (EAT) is an Incredible Growth Stock: 3 Reasons Why
Brinker International (EAT) possesses solid growth attributes, which could help it handily outperform the market.
EAT 
3 Reasons Why Growth Investors Shouldn't Overlook Alphabet (GOOG)
Alphabet (GOOG) possesses solid growth attributes, which could help it handily outperform the market.
GOOG 
3 Reasons Why Growth Investors Shouldn't Overlook CBOE (CBOE)
CBOE (CBOE) possesses solid growth attributes, which could help it handily outperform the market.
CBOE 
3 Reasons Why Growth Investors Shouldn't Overlook FMC Technologies (FTI)
FMC Technologies (FTI) could produce exceptional returns because of its solid growth attributes.
FTI 
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
Abbott Laboratories NYSE: ABT gave the market what it wanted in its Q2 earnings report, affirming that the Exact Sciences acquisition was a good one. The critical takeaways are that comp growth is solid, the Exact Sciences business has traction, and the near-term margin impairment the acquisition brought is less than expected.
EXAS 
Arm's Recent Pullback Is a Gift for Long-Term Investors at Current Levels
Arm's ADRs rallied sharply to a 12-month peak in mid-June, then pulled back significantly over the past four weeks.
ARM 
XQQI: A Better NDX Income Structure I Won't Buy Yet
NEOS Boosted Nasdaq-100 High Income ETF marries 50% NDX leverage with partial, far-OTM covered calls (~44% of leveraged exposure)—a rare leveraged-covered-call variety I genuinely admire structurally and rate the approach highly long-term. Empirically, it captured nearly the full ~29% rally but magnified the ~9% drawdown to ~12%—negative skew, though the option premium shaved some downside off pure leverage. The strike, no-spread, partial-overwrite tilt gears XQQI toward upside capture over income—great for grind-ups and sharp rallies, weak in flat, choppy, or pressured tapes.
XQQI 
JAKKS Pacific's Big Push Into Anime Opens The Door To Excellent Potential
JAKKS Pacific has outperformed the S&P 500, delivering a 131.5% return since December 2021 despite declining revenues and profits. JAKK's valuation remains compelling, supported by a debt-free balance sheet and $64 million in cash, representing significant financial flexibility. Strategic expansion into the high-growth anime merchandise market, with new partnerships and product lines, is a key bullish catalyst.
JAKK 
Palo Alto Networks' stock has been on a tear — and it could go even higher, according to these bulls
The company's shares have roughly doubled over the past three months, as investors have warmed to the idea that AI is increasing the need for cybersecurity products.
PANW 
Tether Freezes $131M USDT Linked to Iran's Central Bank
Tether has frozen $131 million in USDT held in cryptocurrency wallets that U.S. authorities linked to Iran's central bank, after the Treasury Department added four addresses to its sanctions list. The move underscores how the issuer of the world's largest stablecoin can lock down funds tied to sanctioned entities at the contract level.
Dividends Carry the Day With This Small-Cap ETF
Entering Wednesday, the Russell 2000 and S&P SmallCap 600 indexes were up an average of 20.8% year-to-date, confirming small-cap stocks are back with a vengeance. Arguably overlooked in that scenario, some vibrant ETFs represent higher-quality approaches to smaller stocks.
DES 
Beyond Data Centers, Nuclear's Investment Thesis Is Solid
Artificial intelligence and the subsequent data center boom are the primary contributors to the nuclear energy renaissance and investors' newfound enthusiasm for nuclear equities and ETFs. Those ETFs include the ALPS Nautilus SMR, Nuclear & Technology ETF (SMRF).
SMRF 
Oil giant BP shutters its corporate venture arm after 20 years
BP has had an on-again, off-again relationship with climate tech. Now, it's definitely “off.
BP 
